BNP Paribas Financial Markets’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.3M Buy
141,180
+2,454
+2% +$1.38M 0.03% 574
2026
Q1
$77.9M Sell
138,726
-74,836
-35% -$48M 0.04% 483
2025
Q4
$144M Buy
213,562
+52,567
+33% +$35.8M 0.07% 279
2025
Q3
$103M Sell
160,995
-13,871
-8% -$8.42M 0.05% 360
2025
Q2
$93.8M Sell
174,866
-223,287
-56% -$107M 0.05% 345
2025
Q1
$167M Sell
398,153
-43,166
-10% -$18.7M 0.1% 215
2024
Q4
$182M Buy
441,319
+303,936
+221% +$133M 0.1% 182
2024
Q3
$69.4M Buy
137,383
+1,616
+1% +$785K 0.05% 390
2024
Q2
$66.1M Sell
135,767
-8,186
-6% -$4.11M 0.05% 343
2024
Q1
$77.7M Buy
143,953
+48,317
+51% +$26.4M 0.07% 306
2023
Q4
$53.1M Buy
95,636
+11,207
+13% +$5.26M 0.06% 346
2023
Q3
$36.9M Buy
84,429
+550
+0.7% +$274K 0.05% 382
2023
Q2
$42.1M Buy
83,879
+36,542
+77% +$17.5M 0.05% 346
2023
Q1
$23.7M Sell
47,337
-7,464
-14% -$3.57M 0.03% 522
2022
Q4
$22.4M Buy
54,801
+1,007
+2% +$391K 0.03% 607
2022
Q3
$17.5M Sell
53,794
-33,345
-38% -$12.2M 0.03% 695
2022
Q2
$30.6M Sell
87,139
-1,196
-1% -$488K 0.05% 424
2022
Q1
$48.3M Buy
88,335
+37,810
+75% +$19.9M 0.07% 290
2021
Q4
$33.3M Sell
50,525
-4,318
-8% -$2.71M 0.05% 432
2021
Q3
$34.1M Buy
54,843
+12,660
+30% +$8.51M 0.05% 401
2021
Q2
$26.6M Buy
42,183
+8,880
+27% +$4.9M 0.04% 526
2021
Q1
$16.3M Buy
33,303
+16,698
+101% +$8.37M 0.02% 617
2020
Q4
$8.3M Sell
16,605
-64,722
-80% -$29M 0.02% 889
2020
Q3
$32M Sell
81,327
-8,139
-9% -$3.01M 0.05% 379
2020
Q2
$29.5M Buy
89,466
+31,636
+55% +$9.16M 0.05% 341
2020
Q1
$14M Sell
57,830
-2,203
-4% -$575K 0.03% 533
2019
Q4
$15.7M Sell
60,033
-22,740
-27% -$5.99M 0.03% 592
2019
Q3
$22.5M Buy
82,773
+38,491
+87% +$10.7M 0.04% 454
2019
Q2
$12.2M Buy
44,282
+4,077
+10% +$1M 0.02% 644
2019
Q1
$8.99M Buy
40,205
+7,773
+24% +$1.6M 0.02% 743
2018
Q4
$6.03M Sell
32,432
-41,480
-56% -$8.5M 0.01% 836
2018
Q3
$18.5M Buy
73,912
+22,976
+45% +$5.58M 0.03% 556
2018
Q2
$11.1M Buy
50,936
+32,884
+182% +$6.78M 0.02% 762
2018
Q1
$3.45M Sell
18,052
-22,324
-55% -$4.12M 0.01% 1162
2017
Q4
$6.31M Sell
40,376
-9,714
-19% -$1.53M 0.01% 933
2017
Q3
$7.79M Buy
50,090
+22,277
+80% +$3.52M 0.02% 664
2017
Q2
$4.49M Sell
27,813
-42,274
-60% -$6.87M 0.01% 815
2017
Q1
$10.8M Buy
70,087
+43,816
+167% +$6.04M 0.03% 562
2016
Q4
$3.08M Buy
26,271
+18,470
+237% +$2.11M 0.01% 755
2016
Q3
$879K Sell
7,801
-29,841
-79% -$3.15M ﹤0.01% 969
2016
Q2
$3.5M Buy
37,642
+36,661
+3,737% +$3.15M 0.02% 606
2016
Q1
$76.8K Sell
981
-47
-5% -$3.38K ﹤0.01% 1879
2015
Q4
$75K Buy
+1,028
New +$73.3K ﹤0.01% 2525
2015
Q3
Sell
-92
Closed -$5.9K 3653
2015
Q2
$5.9K Sell
92
-2,786
-97% -$193K ﹤0.01% 3409
2015
Q1
$222K Buy
2,878
+916
+47% +$71.3K ﹤0.01% 1536
2014
Q4
$145K Sell
1,962
-584
-23% -$41K ﹤0.01% 1423
2014
Q3
$150K Buy
2,546
+1,786
+235% +$113K ﹤0.01% 2004
2014
Q2
$50.8K Sell
760
-6,718
-90% -$427K ﹤0.01% 2132
2014
Q1
$473K Buy
7,478
+5,404
+261% +$322K ﹤0.01% 1453
2013
Q4
$110K Buy
+2,074
New +$109K ﹤0.01% 1643

Other funds holding IDXX

BNP Paribas Financial Markets's IDXX Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Idexx Laboratories (IDXX) stake by 1.8% in Q2 2026, buying an estimated $1.38M and bringing the position to 141,180 shares worth $74.3M. The position accounts for 0.03% of the portfolio, ranked #574.

BNP Paribas Financial Markets first reported a position in IDXX in Q4 2013 and has held it in 50 quarters since. The position peaked at $182M in Q4 2024. 1,051 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • BNP Paribas Financial Markets held 141,180 shares of Idexx Laboratories worth $74.3M as of Q2 2026.
  • BNP Paribas Financial Markets bought 2,454 Idexx Laboratories shares in Q2 2026, an estimated $1.38M.
  • Idexx Laboratories made up 0.03% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #574 holding.
  • BNP Paribas Financial Markets first reported a position in Idexx Laboratories in Q4 2013 and has held it in 50 quarters since.
  • BNP Paribas Financial Markets's Idexx Laboratories position peaked at $182M in Q4 2024.
  • 1,051 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.